Lopinavir-Ritonavir (Lannett Company, Inc.)
Welcome to the PulseAid listing for the Lopinavir-Ritonavir drug offered from Lannett Company, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lannett Company, Inc. |
| NON-PROPRIETARY NAME: | Lopinavir-Ritonavir |
| SUBSTANCE NAME: | LOPINAVIR; RITONAVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-27 |
| END MARKETING DATE: | 0000-00-00 |
Lopinavir-Ritonavir HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lopinavir-Ritonavir from Lannett Company, Inc. |
| LABELER NAME: | Lannett Company, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80; 20(mg/mL; mg/mL) |
| START MARKETING DATE: | 2016-12-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0527-1947_465735b5-42b8-4286-bd6b-f3ea7c6148da |
| PRODUCT NDC: | 0527-1947 |
| APPLICATION NUMBER: | ANDA207407 |
Other LOPINAVIR; RITONAVIR Pharmaceutical Manufacturers / Labelers:
